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ttp://dx.doi.org/10.1016/j.ajpath.2013.04.013We generated transgenic mice in which human CDX2 gene elements control expression of a tamoxifen-
regulated Cre protein (CDX2P-CreERT2) to allow for inducible gene targeting in intestinal epithelium.
After tamoxifen dosing of CDX2P-CreERT2 mice, Cre activity was detected in the distal ileal, cecal, colonic,
and rectal epithelium, with selected crypt base, transit amplifying, and surface cells all capable of
activating Cre function. Four weeks after tamoxifen dosing of CDX2P-CreERT2 mice carrying a Cre-activated
ﬂuorescent reporter, single crypts were uniformly ﬂuorescence positive or negative, reﬂecting Cre acti-
vation in crypt stem cells. Biallelic inactivation of the Apc tumor suppressor gene via the CDX2P-CreERT2
transgene in colon epithelium led to acute alterations in cell proliferation, apoptosis, and morphology,
along with mitotic spindle misorientation, b-catenin nuclear localization, and induction of the intestinal
stem cell markers Lgr5 and Musashi-1 and the Sox9 transcription factor. Normal mouse colon epithelium
lacks Paneth cells, a key small intestine niche cell type, and Paneth cell differentiation is dependent on
Sox9 function. In Apc-deﬁcient colon epithelium, ectopic Paneth-like cells were seen outside the crypt
base, such as new crypt budding sites. Our data indicate Apc inactivation via CDX2P-CreERT2 targeting in
mouse colon epithelium is sufﬁcient to induce adenomatous changes and the generation of Paneth-like
cells from neoplastic progenitors, with potentially signiﬁcant roles in colon adenoma development and
progression. (Am J Pathol 2013, 183: 493e503; http://dx.doi.org/10.1016/j.ajpath.2013.04.013)Supported by NIH grant R01CA082223-11A2 (E.R.F).
Current address of G.T.B., De Duve Institute, BCHM/GRM, Universite
Catholique de Louvain, Belgium.Colorectal cancer (CRC), like other cancers, manifests ac-
cumulated defects in pathways regulating cell proliferation,
differentiation, and death. The defects include alterations that
lead to novel or increased function of oncogenes and loss of
function of tumor suppressor genes.1 A few genes, such as the
APC, KRAS, TP53, and PIK3CA genes, are each frequently
mutated in CRCs and/or adenomas, but many other genes
are found to be mutated only in subsets of CRCs.1 A recent
continuum model suggests how gene defects may relate to
tumor location in the intestinal tract.2 Recurrent gene defects
with key roles in tumor initiation, progression, and/or main-
tenance are often termed drivers, whereas rare or unique gene
alterations in cancers of a given typemay represent passenger
defects that arose coincident with a driver alteration. Sorting
out driver and passenger alterations in CRCmight be aided by
work with genetically engineered mouse models to assess thestigative Pathology.
.functional signiﬁcance of particular gene defects in tumori-
genesis. In addition, many CRCs arise from adenomatous
precursors, and adenoma development and progression to
CRC may be signiﬁcantly affected by interactions between
colon epithelial cells with genetic and epigenetic defects
and the innate and cellular immune responses to intestinal
microbial communities and products.3
Germline APC gene mutations underlie the familial ade-
nomatous polyposis syndrome, in which hundreds to thou-
sands of adenomas arise in the colon and rectum of affected
individuals in early adult life.4 Approximately 80% of
sporadic adenomas and CRCs have somatic inactivating
Feng et almutations, leading to premature truncation of the APC
protein; the somatic biallelic APC mutations appear to be
early and likely rate-limiting events in neoplastic colon
tumors.1,4 The APC protein functions in regulating the levels
and localization of the free pool of b-catenin protein.5 Among
other possible effects, APC inactivationmaymimic activation
of b-catenin in response to Wnt ligands, with b-catenin
accumulating in the cytoplasm and nucleus and binding to
T-cell factor (TCF) family transcription factors, in turn,
activating expression of varied TCF-regulated genes.5 Gene
expression proﬁling studies suggest the transcriptional pro-
gram induced by b-catenin stabilization in CRCs may
resemble the transcriptional program in normal intestinal and
colon crypt base columnar stem cells (CBCSCs).5,6 Further
work has also implicated b-catenin activation in the spatial
organization and migration of cells in crypts.7,8 The conse-
quences in small intestinal epithelium after biallelic inacti-
vation of Apc have been addressed,8,9 but the acute effects of
Apc inactivation on colon epithelium are not well understood.
Mouse Cdx2 and human CDX2 proteins are homeodomain-
containing transcription factors, and Cdx2/CDX2 expression
is normally largely restricted to small intestine and colon
epithelial cells in the adult.10,11 We previously described
CDX2P-NLSCre transgenic mice in which 9.5 kb of human
CDX2 regulatory sequences were used to regulate expression
of Cre recombinase in caudal tissues during development and
in epithelium of the distal ileum, cecum, colon, and rectum
during adult life.12 By using the CDX2P-NLSCre transgene
to inactivate one Apc allele somatically, we generated
a mouse model of colonic adenoma-carcinoma progression.
We also previously described CDX2P-G22Cre transgenic
mice with mosaic Cre expression in a subset of colorectal
crypts,13 and we used the CDX2P-G22Cre transgenic mice
to study phenotypic consequences in colon epithelium after
biallelic, inactivating mutations in Apc or oncogenic gain-of-
function mutations in Kras.14 Transgenic mice expressing
ligand [tamoxifen (TAM)]-regulated Cre recombinased
so-called CreERT2 [a fusion protein containing Cre recom-
binase sequences fused to a mutated ligand-binding domain
of human estrogen receptor 1 protein that responds to TAM
and not endogenous estrogen (ERT2)]din colon epithelium
might allow for studies of the effects of targeting a wide
array of genes in adult colon epithelium. We describe the
generation of CDX2P-CreERT2 transgenic mice. We used
reporter lines with Cre-activated transgenes [b-galactosidase
(b-gal)15 and enhanced yellow ﬂuorescent protein (EYFP)16]
to monitor functional Cre induction in response to TAM
treatment. We also report in detail on the temporal sequence
of events after Cre-mediated inactivation of Apc in colon
crypts, including the generation of ectopic Paneth-like cells in
Apc-deﬁcient colon epithelium at positions outside the crypt
base, such as where new crypt budding occurs. Given ﬁndings
implicating Paneth cells as a key supporting cell type in the
stem cell niche in normal intestinal crypts,17 the data imply
a potentially signiﬁcant role for Paneth cells in neoplastic
progression.494Materials and Methods
Plasmids
The 9.5-kb fragment containing 50-ﬂanking sequence from
the human CDX2 promoter region has previously been
described.18 To assemble the CDX2P-CreERT2 transgene
construct, both CDX2 promoter and a CreERT2 DNA frag-
ment were assembled into the pcDNA3 vector (Invitrogen,
San Diego, CA), which provides a polyadenylation cassette
from the bovine growth hormone gene (BGHpA).Mice
CDX2P-CreERT2 transgenic founders on amixed background
[C57BL6/J (B6)  SJL/J] were back-crossed with B6 mice.
To monitor Cre expression, male F2 mice from the transgenic
line were intercrossed with mice carrying the Gt(ROSA)
26Sortm1Sor/J reporter allele (R26R)15 or the Gt(ROSA)26
Sor tm1(EYFP)Cos/J reporter allele (EYFP)16 (The Jackson
Laboratory, Bar Harbor, ME). As a comparison, we crossed
Lgr5-EGFP-IRES-CreERT2 (B6.129P2-Lgr5tm1(cre/ERT2)Cle/J)
mice19 with Gt(ROSA)26Sortm1Sor/J reporter mice.
KrasLSL-G12D/þ mice have been described previously.20 We
crossed KrasLSL-G12D/þ mice with CDX2P-CreERT2 trans-
genic mice to activate the mutant Kras allele in the intestinal
tract. To targetApc alleles,CDX2P-CreERT2mice orCDX2P-
NLSCre mice were intercrossed with mice homozygous for
an Apc targeted allele (Apcﬂox/ﬂox, 580S) as described.12,13
Animal husbandry and experimental procedures were per-
formedwith the approval of theUniversity Committee onUse
and Care of Animals, University of Michigan, and according
to Michigan state and US federal regulations. All the mice
were housed in speciﬁc-pathogen free conditions. After
weaning, rodent 5001 chow and automatically supplied water
were provided ad libitum to mice. The transgenic CDX2P-
CreERT2 mice have been deposited with Jackson Laboratory
(Jax stock No. 022390).TAM Treatment
Mice with CDX2P-CreERT2 transgene were injected i.p.
with TAM (Sigma-Aldrich, St. Louis, MO) dissolved in
corn oil. For single TAM dosing, we used 200 mg/kg; for
three consecutive daily doses, we administered TAM at
100 mg/kg per dose. Mice were injected with TAM at 2 to
3 months of age. Animals were euthanized and analyzed at
various time points after the single injection or the ﬁnal
injection of three was given.Human Tissue Specimens
Deidentiﬁed human colon tissue specimens were provided
by the Department of Pathology at the University of
Michigan Health System (Ann Arbor, MI).ajp.amjpathol.org - The American Journal of Pathology
Conditional Apc Gene TargetingIHC, Immunoﬂuorescence, and b-Gal Analysis
Mouse tissues were prepared for parafﬁn-embedding or
cryosectioning as described previously.13 For assessment of
cell proliferation, mice were pulsed with 5-bromo-2-
deoxyuridine (BrdU; Sigma-Aldrich) for 1 hour before the
mice were euthanized. Sections of parafﬁn-embedded
human or mouse tissues were subjected to immunohisto-
chemical (IHC) analysis as described.21 The following
primary antibodies were used for IHC analysis with sections
of parafﬁn-embedded tissues: mouse anti-BrdU (1:500; BD
Biosciences, San Jose, CA), rabbit anti-lysozyme (1:2000;
Dako, Carpinteria, CA), and mouse antieb-catenin (1:800;
BD Biosciences). Histochemical identiﬁcation of intestinal
goblet cells was performed on parafﬁn sections with Alcian
blue (Sigma-Aldrich) after IHC with lysozyme. For BrdU
staining, tissue sections were treated with 2N HCl at 37C
for 30 minutes after performing antigen retrieval with citrate
buffer (pH 6.0; Biogenex, San Ramon, CA). For immuno-
ﬂuorescence of frozen sectioned tissues, mouse colon and
intestinal tissues were ﬁxed in 4% paraformaldehyde over-
night, cryoprotected, and frozen in OCT. Standard immu-
noﬂuorescence staining was performed on 6-mm frozen
sections. Antibodies included mouse antieb-catenin (1:800;
BD Biosciences), rabbit anti-lysozyme (1:1000; Dako),
rabbit anti-chromogranin A (1:1000; ImmunoStar, Hudson,
WI), goat antiec-kit (1:200; R&D Systems, Minneapolis,
MN), and goat anti-Reg4 (1:50; R&D Systems). For
immunoﬂuorescence using parafﬁn-embedded tissues, the
following primary antibodies were used: rabbit anti-Sox9
(1:200; Millipore, Temecula, CA), rat antieMusashi-1
(Msi1) (1:500; a gift from Dr. Hideyuki Okano22,23), mouse
antiea-tubulin (1:1000; Sigma-Aldrich), rabbit anti-Dclk1
(1:200; Epitomics, Burlingame, CA), and rabbit anti-Crb3
(1:1000; kindly provided by Dr. Benjamin Margolis at
University of Michigan). The secondary antibodies used
were Alexa ﬂuor 488-conjugated donkey anti-goat, Alexa
ﬂuor 488-conjugated donkey anti-rabbit, Alexa ﬂuor 488-
conjugated goat anti-rabbit, Alexa ﬂuor 594-conjugated goat
anti-mouse, Alexa ﬂuor 488-conjugated goat anti-mouse,
Alexa ﬂuor 594-conjugated goat anti-rabbit, and Alexa
ﬂuor 488-conjugated goat anti-rat (Molecular Probes, Invi-
trogen, Carlsbad, CA), diluted at 1:1000. DNA was labeled
by Hoechst 33342 (Molecular Probes, Invitrogen) by adding
to the washing buffer at 5 mg/mL. For detection of goblet
cells with ﬂuorescence, frozen sections of mouse proximal
colon tissues were incubated with rhodamine Dolichos
biﬂorus agglutinin (1:500 in PBS; Vector Laboratories,
Burlingame, CA) at 37C for 1 hour. b-gal analysis was
performed as described previously.13
Mitotic Spindle Axis Assessment
The spindle angle was deﬁned by the orientation of mitotic
spindle based on a-tubulin staining, The adjacent apical
membrane of the mitotic cell was deﬁned by Crb3 staining.The American Journal of Pathology - ajp.amjpathol.orgThe mitotic spindle axis angle relative to the planar axis of
the cells was then measured by ImageJ version 1.42q
(National Institutes of Health, Bethesda, MD).
Statistical Analysis
All data were evaluated by Student’s t-test, and asterisks
denote signiﬁcance with P < 0.05. Error bars denote SDs.
Results
TAM-Regulated Cre Function in Intestinal Epithelium
of CDX2P-CreERT2 Mice
We generated a CDX2P-CreERT2 transgenic construct
(Figure 1A) and addressed the ability of theCDX2P-CreERT2
transgene to target loxP-containing transgenes in vivo in
murine intestinal epithelial tissues and speciﬁcally in
response to TAM treatment. To assess TAM induction of
Cre activity, we used two different transgenic mouse lines
(R26R and EYFP) carrying integrated reporter gene
sequences (ie, b-gal or EYFP, respectively) at the ubiqui-
tously expressed Rosa26 locus.15,16 The reporter gene
products are only produced after Cre-mediated excision of
a transcriptional stop element ﬂanked by loxP sites. We
bred selected CDX2P-CreERT2 transgenic founder mice to
the R26R line and treated CDX2P-CreERT2 R26R progeny
with TAM to activate CreERT2 function. To detect acti-
vation of b-gal expression after Cre-mediated targeting in
the R26R line, the intestinal tract and other tissues were
stained with X-gal, ﬁxed, and analyzed by gross and
microscopic analysis. We identiﬁed three transgenic lines
with TAM-inducible b-gal expression in colon epithelium
(data not shown) and focused here on one line (No. 752). In
the absence of TAM treatment, we found no evidence of
b-gal expression in mouse intestinal tissues (Supplemental
Figure S1). Three daily TAM injections in 2- to 3-month-
old CDX2P-CreERT2 R26R mice led to readily detectable
expression of b-gal in the mucosa in the cecum and
proximal colon by 3 days after the ﬁnal TAM dose and in
mucosa of the cecum, colon, and rectum by 2 months after
the ﬁnal TAM dose, along with limited and patchy b-gal
staining seen in the distal ileum (Supplemental Figure S1).
In contrast to the largely colonic pattern of TAM-induced
Cre recombinase function in CDX2P-CreERT2 mice, at
2 months after three daily doses of TAM in adult Lgr5-
EGFP-IRES-CreERT2 R26R mice,19 Cre function was
activated robustly and broadly only in the proximal third of
the small intestine, with patchy and limited b-gal expres-
sion in the remainder of the small intestine, cecum, colon,
and rectum (Supplemental Figure S1).
We also performed studies of Cre-mediated activation of
EYFP expression from the Rosa26 locus in intestinal
tissues to conﬁrm and extend the TAM-induced b-gal
results with the CDX2P-CreERT2 line 752. Three days after
the last of three daily TAM doses, we studied epithelium in495
Figure 1 CDX2P-CreERT2 transgenic mice and TAM induction of Cre-
mediated recombination in the intestinal tract. A: Schematic representation
of CDX2P-CreERT2 transgene construct, where a roughly 9.5-kb human CDX2
fragment was cloned upstream of the other sequences in the construct,
including CreERT2 and bovine growth hormone polyA (BGHpA) elements. B:
Representative EYFP images (green), counterstained with Hoechst 33342
(blue) tomark nuclei, in the intestinal tract of CDX2P-CreERT2mouse with EYFP
reporter. Cre-mediated EYFP expression was detected speciﬁcally in epithelial
cells in the terminal ileum, cecum, and colon at 3 days after the third of three
daily doses of TAM.C: EYFP imaging (green) in proximal colonof CDX2P-CreERT2
mouse after 1 day, 3 days, 2 weeks, 3 weeks, and 10months after a single TAM
dose. CDX2P-CreERT2 mouse with no TAM treatment was used to demonstrate
the lack of background Cre activity. D: EYFP imaging (green), co-stained with
rhodamine Dolichos biﬂorus agglutinin to mark Goblet cells (red), or with
chromogranin A to mark enteroendocrine cells (red), in the proximal colon of
CDX2P-CreERT2 EYFP reporter mice at 2 months after TAM dosing (left panels).
Co-staining with lysozyme (red) in terminal ileum demonstrates the presence
of Paneth cells within the induced green clones (right panel). Representative
double-positive cells of interest in the panels are outlined with dashed lines.
Scale bars: 100 mm (B); 50 mm (C); 20 mm (D).
Feng et althe duodenum, jejunum, ileum, cecum, and various regions
of the colon and rectum for EYFP expression, ﬁnding
TAM-induced EYFP expression in epithelial cells from
terminal ileum to rectum, with the strongest induction of
Cre activity at early time points in the cecum and proximal
colon (Figure 1B). In studies that focused on the proximal
colon of 2- to 3-month-old CDX2P-CreERT2 mice treated
with a single dose of TAM, we found a few scattered
EYFP cells at 1 day after the TAM dose, with larger
numbers of EYFP-positive cells at 3 days and 2 weeks. By
3 to 4 weeks after a single TAM dose, individual crypts
were entirely EYFP positive or negative, presumably
reﬂecting Cre-mediated activation of the EYFP reporter in
crypt stem cells, which then were able to maintain EYFP-
positive crypts for at least 10 months (Figure 1C). Further,
consistent with the notion that TAM-induced Cre activa-
tion could occur in crypt stem cells, differentiated goblet
and enteroendocrine cells in colon and Paneth cells in
small intestine expressed EYFP (Figure 1D).496Biallelic Apc Inactivation in Colon Epithelium Acutely
Alters Cell Proliferation, Death, and Expression of Wnt
Pathway Genes and Stem Cell Markers
We analyzed the phenotypic effects of TAM-induced
conditional inactivation of both Apc alleles in intestinal
tissues of 2- to 3-month-old CDX2P-CreERT2 Apcﬂox/ﬂox
mice. At 27 days after a single TAM dose to inactivate Apc,
we found hyperplasia of the epithelium in the terminal
ileum, cecum, and colon, along with dysplastic changes
such as those in adenomatous epithelium in humans and
mice (Supplemental Figure S2). Time course studies indi-
cated that within 5 days of a single TAM dose, CDX2P-
CreERT2 Apcﬂox/ﬂox mice had signiﬁcant hyperplastic and
dysplastic alterations in proximal colon epithelium
(Supplemental Figure S2), indicating Apc inactivation is
sufﬁcient to induce adenomatous epithelium in the mouse
colon. Although DNA synthesis and cell proliferation in
normal mouse colon epithelium are largely restricted to theajp.amjpathol.org - The American Journal of Pathology
Figure 2 Conditional inactivation of Apc in mouse colon is linked to induction of Sox9 expression and initiation of crypt budding. Proximal colon tissues
from wild-type (control) or CDX2P-CreERT2 Apcﬂox/ﬂox mice were co-stained for b-catenin (red; A) and Sox9 (green; B) and counterstained with Hoechst 33342
(blue) after 1 day, 2 days, 4 days, 5 days, and 7 days after a single TAM dose. The budded crypt regions were outlined with dashed lines, which indicate
nuclear staining for both Sox9 and b-catenin. Arrows indicate the cells with increased Sox9 expression induced by inactivation of Apc at early time points but
without b-catenin induction shown as membrane staining. Scale bar Z 20 mm.
Conditional Apc Gene Targetingbottom third to half of each crypt, within the ﬁrst 2 days
after TAM dosing of CDX2P-CreERT2 Apcﬂox/ﬂox mice, we
observed increased DNA synthesis in cells in the upper half
of the crypt, with further increases over time (Supplemental
Figure S3). Marked increases in the number of apoptotic
cells were also seen in proximal colon epithelial glands by
6 days after Apc targeting, with further increases in the
percentage of apoptotic cells over time (Supplemental
Figure S3).
After a single TAM dose in 2- to 3-month-old CDX2P-
CreERT2 Apcﬂox/ﬂox mice, we found increased b-catenin
expression could be seen in subsets of epithelial cells from 4
days onward after the TAM dose (Figure 2A). Cells with
elevated cytoplasmic and occasional nuclear b-catenin
expression were more often localized near crypt base
regions, including the base regions of recently branched,
newly arising glands (Figure 2A). Consistent with the
elevated b-catenin levels, increased expression of Sox9,
a transcription factor protein encoded by a b-catenin/TCF-
regulated gene,24 was found in Apc-mutant (Apcmin) colon
epithelium (Figure 2B). However, Sox9 induction was more
readily apparent at earlier time points than changes in
b-catenin expression (Figure 2B), which may reﬂect the
ability to detect even modest changes in Sox9 expression,
because of the low basal levels of Sox9 expression in normal
colon epithelium. Interestingly, we also observed frequent
crypt buddings (Figure 2) and adenomatous features (Figure 2
and Supplemental Figure S2) in the cells with strong b-catenin
and Sox9 nuclear staining and at cell positions not restricted to
the presumptive CBCSCs in normal crypts. These data indi-
cate that de novo crypts during adenoma formation can
perhaps be induced by Apc inactivation in colon crypt cells
other than the presumptive CBCSCs. It is uncertain whether
the ability of the de novo crypts arising in the colon to persistThe American Journal of Pathology - ajp.amjpathol.organd/or progress may depend on their cell of origin, as appears
to be the case when Apc is inactivated in the small intestine.9
After Apc inactivation, we were also able to detect strong
induction of enhanced green ﬂuorescent protein (EGFP)
expression from the Lgr5 locus (Lgr5-EGFP), a b-catenin/
TCF-regulated gene and a marker of presumptive CBCSCs in
normal colon,19 along with increased expression of Msi1
RNA-binding protein, another presumptive stem cell
marker25,26 (Figure 3). A recent study has suggested that the
Dclk1 proteinmight be amarker to distinguish between tumor
stem cells and normal stem cells in the intestine and speciﬁ-
cally that Dclk1 marks potential tumor stem cells in Apcmin
small intestine tumors.27 Although Dclk1 expression was
seen in one to three cells in each normal colon crypt, Dclk1-
expressing cells were rarely seen in Apc-defective colon
crypts (Supplemental Figure S4).
Apc Inactivation Rapidly Generates Ectopic Paneth
Cells in Colon Epithelium
Paneth cells, a specialized cell type intercalated with
CBCSCs in the normal small intestine, have been proposed
to play a critical functional role in maintenance of the crypt
stem cell niche, perhaps via secretion of trophic factors for
CBCSCs, such as Wnts, Notch, and epidermal growth factor
receptor ligands.17 Sox9 function is required for Paneth cell
differentiation,28,29 and Apc inactivation in small intestine
epithelium has been found to generate increased numbers of
lysozyme-expressing Paneth-like cells in the resultant ade-
nomatous epithelium.8,30,31 Normal mouse colon epithelium
lacks Paneth cells. However, within 4 days after TAM
dosing of 2- to 3-month-old CDX2P-CreERT2 Apcﬂox/ﬂox
mice, we found lysozyme-expressing Paneth-like cells in the
targeted colon epithelium (Figure 4). Lysozyme-expressing497
Figure 3 Biallelic Apc inactivation in mouse colon epithelium induces
intestinal stem cell marker expression. A: EGFP imaging (green), counter-
stained with Hoechst 33342 (blue) to mark nuclei, in the proximal colon of
the CDX2P-CreERT2, Lgr5-EGFP-IRES-CreERT2, Apc ﬂox/ﬂox mouse or the control
Lgr5-EGFP-IRES-CreERT2 mouse at 20 days after TAM dosing. Arrows indicate
the cells positive for Lgr5 at a region close to the luminal surface in mouse
with Apc inactivation. B: Immunoﬂuorescence staining for Msi1 (green)
and counterstained with Hoechst 33342 (blue) in the proximal colon of
wild-type (control) or CDX2P-CreERT2 Apcﬂox/ﬂox mice at 21 days after TAM
induction. Arrows indicate the cells positive for Msi1 at the crypt base in
normal colon epithelium. Scale bar Z 50 mm.
Figure 4 Inactivation of Apc, b-catenin expression, and crypt budding
associated with altered cell differentiation in mouse colon. IHC staining for
b-catenin (A) and lysozyme (B) in the proximal colon of wild-type (control)
or CDX2P-CreERT2 Apcﬂox/ﬂox mice at 4 days, 5 days, and 7 days after a single
TAM induction. Insets: High magniﬁcations for the boxed area. Scale bars:
20 mm (low magniﬁcations); 10 mm (insets, high magniﬁcations).
Feng et alcells were preferentially located in crypt regions with strong
b-catenin expression, including sometimes near the base of
crypts undergoing branching or ﬁssion (Figure 4), implying
that the Paneth-like cells in Apc-mutant colon epithelium
might contribute to a conducive environment, perhaps akin
to a niche, for potential adenoma stem cells outside the
normal crypt base. Crypt branching, a potential key early
event in small intestinal and colon polyp formation, was
described as the formation of an outpocketing pouch in
a single crypt in mice carrying a truncation mutation at
codon 716 of Apc (ApcD716).32
In normal mouse small intestinal epithelium, lysozyme-
expressing Paneth cells are restricted to the crypt base and
lack expression of markers for other intestinal cell lineages,
such as the Alcian blue staining that marks goblet cells with
intestinal-type mucin expression (Figure 5A). In Apc-mutant
mouse colon epithelium, although there was a notable
decrease in Alcian blue staining, reﬂecting loss of differ-
entiated goblet cells, a few Alcian blue-staining cells were
seen and a subset of the Alcian blue-positive cells also
expressed lysozyme (Figure 5A). Thus, the data suggest Apc
inactivation had altered the colon epithelial differentiation
program to generate possible bipotential precursor cells that
could differentiate into goblet and/or Paneth cell fates.
Studies of human colon adenomas demonstrated lysozyme-
expressing Paneth-like cells were also frequent in the lesions
studied and a subset of the lysozyme-expressing adenoma
cells also stained with Alcian blue (Figure 5B). After
Apc inactivation in colon epithelium of 2- to 3-month-old
CDX2P-CreERT2 Apcﬂox/ﬂox mice, although many of the
lysozyme-expressing Apc-mutant cells were not actively
synthesizing DNA, a subset of the lysozyme-expressing498colon epithelial cells did in fact reveal BrdU incorporation
(Figure 5C). This result suggests that these lysozyme-
expressing cells might not only have an altered differentia-
tion program but also have an altered proliferation potential.
To further evaluate the differentiation status of lysozyme-
expressing colon epithelial cells, we analyzed the expres-
sion of two putative markers of crypt base secretory cells.17,33
Most of the lysozyme-expressing colon epithelial cells also
expressed the crypt base secretory cell marker known as
regenerating islet-derived family member-4 (Reg4),17,33 but
these cells represented only a fraction of Reg4-positive cells
(Figure 5D). c-Kit has been suggested as a marker of
potential crypt base secretory cells that support Lgr5þ colon
stem cells in the mouse small intestine.33 Although c-Kit
expression was seen in the normal mouse colon crypt base
region, the lysozyme-expressing Apc-mutant colon epithelial
cells lacked c-Kit expression (Figure 5D).
Apc-Defective Mouse Colon Crypts Acutely Manifest
Spindle Axis Abnormalities
The orientation of the mitotic spindle is believed to have
a critical role in regulating cell fate decisions in the intestine
and other tissues because the cytokinetic cleavage plane that
generates two daughter cells is oriented perpendicular to theajp.amjpathol.org - The American Journal of Pathology
Figure 5 Characteristics of lysozyme-expressing
cells in Apc-defective colon epithelium. A: IHC stain-
ing for lysozyme, followed by Alcian blue staining, in
the proximal colon (left upper panel) and ileum (left
bottom panel) from a wild-type mouse (control) or
proximal colon from a CDX2P-CreERT2 Apcﬂox/ﬂoxmouse
(right panel) at 21 days after TAM dosing. The crypt
base (bottom right panel) and a region close to the
luminal surface (top right panel) are shown. B: IHC
staining for lysozyme, followed by Alcian blue stain-
ing, in control human colon mucosa (left panel) and
two human adenomas (right panel). Arrowheads
indicate the double-positive cells for lysozyme and
Alcian blue staining; arrows indicate the cells only
positive for lysozyme. C: Proximal colon tissues from
wild-type (control) or TAM-induced(for 7 days)CDX2P-
CreERT2 Apcﬂox/ﬂox (right panel) mice were co-stained
for BrdU (green) and lysozyme (red) and counter-
stained with Hoechst 33342 (blue). The double posi-
tive cells wereoutlinedwithdashed lines.D:Proximal
colon tissues fromwild-type (control) or TAM-induced
(for 7 days) CDX2P-CreERT2 Apcﬂox/ﬂox (bottom panel)
mice were stained for Reg4 (left panel, green) or c-Kit
(right panel, green), co-stained with lysozyme (red),
and counterstained with Hoechst 33342 (blue). The
budded crypts were outlined with dashed lines. Scale
barZ 20 mm.
Conditional Apc Gene Targetingspindle axis.34,35 In a tissue that has a single columnar cell
layer, such as colon epithelium, if the spindle axis is
oriented in a planar fashion (ie, parallel to the crypt axis),
cell division generates two daughter cells with essentially
equivalent luminal (apical) and basement (extracellular
matrix) surfaces. If the spindle axis is not oriented parallel to
the crypt axis, cell division generates daughter cells with
differences in luminal and basement membrane surfaces,
perhaps resulting in differential exposures of the daughter
cells to extracellular cues and/or unequal segregation of
cytoplasmic determinants, with the potential for resultant
differences in the cell fates adopted by the two daughter
cells.34,35 Prior work has indicated that Apc heterozygous
mutant and homozygous intestinal epithelial cells have
mitotic spindle axis orientation defects.36e38
We have assessed spindle axis orientation in mitotic cells
independent of their position in the crypt in colon epithelial
tissues from wild-type mice, as well as mice with heterozy-
gous Apc somatic defects (CDX2P-NLSCre Apcﬂox/þ mice)
and 2- to 3-month-old CDX2P-CreERT2 Apcﬂox/ﬂoxmice at 21
days after a single TAM dose to inactivate both Apc alleles.
We also studied mitotic spindle orientation in hyperplastic
and hyperproliferative colon epithelium of mice where a Cre
recombinase-dependent Kras mutant oncogenic allele20 wasThe American Journal of Pathology - ajp.amjpathol.orgactivated by TAM-induced activation of the CDXP-CreERT2
transgene. Most mitoses evaluated in all mouse tissues were
outside the crypt base region. In >75% of mitotic cells from
normal mouse colon epithelium and Apc heterozygous-
mutant and Kras-mutant colon epithelium, mitotic spindles
were aligned within 30 of the planar (crypt) axis, but only
approximately 50% of Apc homozygous mutant epithelial
cells hadmitotic spindle axeswithin the 30 of the planar axis,
with roughly 30% of Apc homozygous mutant cells having
spindle axes from 30 to 60 out of planar alignment and
nearly 20% showing spindle axes between 60 and 90 out of
planar alignment (Figure 6, A and B). Similar to the situation
in the mouse tissues, we found that human colon adenomas,
most ofwhich harbor biallelicAPCmutations, had upwards of
50% of the mitotic cells with spindle axis orientation 30
degrees out of the planar axis, whereas >75% of the mitotic
epithelial cells in normal colon and human hyperplastic
polyps withKRAS-activatingmutations had their spindle axes
within 30 of the planar axis (Figure 6, C and D).
Discussion
Several genetically engineered mouse models permitting
inducible Cre recombinase targeting of loxP-containing499
Figure 6 Misalignment of mitotic spindle axes with the planar axis in mouse and human colon adenomatous epithelium but not in hyperplastic Kras-
mutant mouse colon epithelium or human hyperplastic polyps (HP). A: Proximal colon tissues from wild-type (control) or CDX2P-CreERT2 KrasLSL-G12D/þ (middle
panel) mice or CDX2P-CreERT2 Apcﬂox/ﬂox (right panel) mice at 21 days after TAM dosing were co-stained for a-tubulin (green) and Crb3 (red) and coun-
terstained with Hoechst 33342 (blue). Representative low- (upper panel) or high-magniﬁcation (lower panel) images are shown. B: The spindle angles are
deﬁned by the orientation of mitotic spindles versus the most adjacent apical membrane indicated by Crb3 staining. Quantiﬁcation for the indicated tissues is
shown, including colon tissues from CDX2P-NLSCre Apc ﬂox/þ (heterozygous) mice. C: Tissues from normal human colon, human hyperplastic polyps, or human
adenomas were co-stained for a-tubulin (green) and Crb3 (red) and counterstained with Hoechst 33342 (blue). Representative low- (upper panel) or high-
magniﬁcation (lower panel) images are shown. A and C: Double-headed arrows indicate the orientation of mitotic spindles. Solid lines indicate the most
adjacent apical membrane of the mitotic cell, which is used as a reference for the spindle angle. Dashed lines indicate the border of the basement membrane.
D: Quantiﬁcation for panel C was shown. *P < 0.01 compared with the normal tissues (nZ 3 and >100 crypts were counted). Scale bars: 20 mm (A and C, low
magniﬁcations); 10 mm (A and C, high magniﬁcations). *P < 0.01 compared with the normal tissues (n Z 3 and >100 crypts were counted).
Feng et algenes in intestinal tissues have been described, such as
Villin-CreERT2, AhCre, and Lgr5-EGFP-IRES-CreERT2
transgenic mice.19,39,40 All three of these transgenic lines
have proven valuable for targeting genes of interest in
intestinal tissues, such as the Apc and Ctnnb1 genes and
various other genes implicated in tumorigenesis and/or cell
fate speciﬁcation. Nonetheless, because the Villin promoter
elements are quite broadly active throughout the intestinal
tract and the Lgr5 and Ah (Cyp1A) genes are also expressed
in tissues other than epithelium of the intestinal tract, there
are challenges in using the respective Cre recombinase
transgenes to assess the physiologic consequences speciﬁ-
cally in the colon epithelium for genes of interest. In our
prior work, we described the use of upstream regulatory
elements of the human CDX2 gene (CDX2P) for directing
transgene expression to most epithelial cells of the very
distal ileum, cecum, colon, and rectum during adult life.12500We have described here the generation and characterization
of CDX2P-CreERT2 transgenic mice, including the utility of
the CDX2P-CreERT2 transgene for TAM-dependent target-
ing of reporter genes in colon epithelium and for studies of
ligand-regulated targeting of other genes of interest, such as
the Apc tumor suppressor gene.
Prior studies of colon epithelium from patients with
familial adenomatous polyposis demonstrated clear-cut
changes in cell proliferation patterns in ﬂat colonic mucosa,
with focal and widespread loss of the normal repression of
DNA synthesis from the upper portion of the crypt in the
colon mucosa of those with familial adenomatous poly-
posis.41,42 Most published studies of the physiologic conse-
quences of biallelic inactivation of the mouse Apc gene have
emphasized effects seen in small intestine epithelium.
Among the phenotypic effects reported in intestinal epithe-
lium after Apc biallelic inactivation were the following:ajp.amjpathol.org - The American Journal of Pathology
Conditional Apc Gene Targetingincreased proliferation; increased apoptosis; decreased cell
migration along the crypt-villus axis; and altered differenti-
ation, including loss of villus markers and goblet cells and
the generation of increased numbers of Paneth cells, espe-
cially at ectopic positions outside the crypt base.8,30 Only
a few publications have reported in any depth on selected
effects of inactivating Apc or modulating b-catenin function
in mouse colon epithelium, such as the article by Andreu
et al,31 indicating that Apc inactivation led to the apparent de
novo speciﬁcation of Paneth cells in colon epithelium. Also,
a recent article from Hirata et al43 reported that activation of
a stabilized mutant form of b-catenin had variable effects on
cell phenotypes, depending on the levels of b-catenin protein
expression achieved in colon epithelium of adult mice,
including increased number of Lgr5þ cells, increased crypt
ﬁssion rates in colon epithelium, and de novo crypt formation.
In our studies, we established that multiple effects seen
after Apc biallelic inactivation in small intestine epithelium
are also seen when Apc is inactivated in colon epithelium,
including the following: increased cell proliferation,
increased apoptosis, decreased number of goblet cells, and
the generation of ectopic Paneth cells. We also found that
induction of certain b-catenin/TCF-regulated genes, such as
Sox9, was even more easily detectable than b-catenin stabi-
lization at early time points after Apc inactivation in the colon
epithelium. Also, stem cell marker gene expression, such as
that for the Wnt pathway-regulated Lgr5 gene and for Msi1,
which both normally mark presumptive CBCSCs, could be
seen in a large fraction of the Apc-defective colon epithelial
cells, independent of cell position within a crypt. Of some
interest, although theDclk1 gene has recently been suggested
to be a marker for cancer stem cells in small intestine tumors
arising in Apcmin mutant mice and not a marker of normal
intestinal stem cells,27 we found very rare Dclk1-expressing
cells in Apc-defective mouse colon epithelium, raising some
questions about the proposal that Dclk1 expression will be
a key marker for colon cancer stem cells in human.
The rapid induction of Sox9 protein expression in Apc-
defective colon epithelium is potentially noteworthy, given
not only that Sox9 gene expression is regulated by Wnt/b-
catenin/TCF signaling but also that the Sox9 protein appears
to function as a negative feedback regulator of b-catenin
function in the nucleus in some settings.24,28 Perhaps more
signiﬁcantly, Sox9 has been implicated as a key factor for
the differentiation of Paneth cells in small intestine epithe-
lium.28,29 The potent induction of Sox9 in Apc/APC-mutant
colon epithelium may be a contributing factor to the gen-
eration of the lysozyme-expressing Paneth-like cells seen
in mouse and human adenomatous tissues in the colon,
including in our studies. We have chosen to term the various
lysozyme-expressing cells that we observed in our studies as
Paneth-like because a subset of the ectopically generated
cells seem to express both lysozyme, characteristic of Pan-
eth cells, and intestinal mucin, characteristic of goblet cells.
In addition, some of the lysozyme-expressing Apc-defective
mouse colon epithelial cells incorporated BrdU, whereasThe American Journal of Pathology - ajp.amjpathol.orgmature Paneth cells are thought to be postmitotic. Interest-
ingly, prior work has demonstrated the induction of ectopic
expression of Paneth cell makers in intestinal villus and colon
crypts in mice maintained on a Western-style diet, which can
induce the development of small and large intestine tumors
in the mice after long-term exposure.44 Although dietary-
induced changes in gene expression proﬁles were distinct
from those in mice with genetic risk of intestinal tumors due
to a constitutional Apc mutation,44 mice with nutritional or
genetic risk may share some common features, such as
ectopic expression of Paneth-like cells, suggesting some
overlapping mechanisms in tumor development.
Although it was initially suggested that Paneth cells were
an essential cell type in the stem cell niche supporting
CBCSCs,17 several recent studies suggest that Paneth cells
may not be absolutely required for development and main-
tenance of CBCSCs in vivo.14,28,29,45,46 It has also been
suggested that Paneth cells are not required for the initiation
of Apc mutation-induced adenomatous epithelium in the
small intestine in the mouse.45 Nevertheless, given the likely
important trophic role of Paneth cell surface and secreted
factors on CBCSCs, including perhaps Notch ligands,
R-spondins, and epidermal growth factor receptor ligands, it is
possible that the Paneth-like cells generated by the neoplastic
progenitors in Apc-mutant colon epithelium may play
important contributing roles in adenoma formation and
progression. Consistent with this suggestion, we ﬁnd that the
Paneth-like cells present at early time points after Apc inac-
tivation were not infrequently associated with stabilized b-
catenin staining patterns and new crypt branching sites. In our
study, a fraction of lysozyme-expressing cells had indications
of altered proliferation and differentiation properties, sug-
gesting that these Paneth-like cells might have multilineage
potential or be induced to reenter the cell cycle to produce
more such cells as a support for tumor growth. Two recent
studies have suggested a key role for a subset of intestinal crypt
cells expressing Paneth cell markers as the potential reserve
cells for the more rapidly cycling Lgr5-positive CBCSCs in
the setting of intestinal homeostasis or injury.47,48 Further
studies will be needed to clarify the possible functional
contribution of the Paneth-like cells present in Apc/APC-
mutant colon epithelium and human adenomas. The Paneth-
like cells could function as potential reserve stem cells,
sources of growth factor ligands, and/or in other yet to be
identiﬁed ways in tumor development and progression.
Besides the changes in proliferation and loss of normal
differentiation patterns that developed very rapidly after Apc
inactivation in murine colon epithelium, we observed the
rapid acquisition of nuclear stratiﬁcation and other changes in
cell morphology and polarity akin to those seen in adeno-
matous epithelium in human and mouse. The means by
which Apc inactivation contributes to these complex changes
in cell phenotype are not well understood. In previously
published work, it has been suggested that even nonneo-
plastic Apc heterozygous mutant epithelium may demon-
strate changes in mitotic spindle axis orientation, including in501
Feng et alpresumptive CBCSCs.35e38 In our studies, we focused on the
marked changes from the typical planar spindle polarity
present in most mitotic normal colon epithelial cells that were
seen in Apc/APC-mutant colon epithelium of mice and
humans, respectively. Speciﬁcally, although only a small
fraction of normal mitotic spindle axes were oriented 30
from the planar axis, roughly 50% of Apc/APC-mutant
epithelium was >30 out of alignment with the planar axis.
Spindle misorientation might in fact be a key contributing
feature to dysplasia and other cytologic features character-
istic of adenomatous epithelium and its propensity to be at
risk for neoplastic progression. In contrast, spindle misori-
entation might be lacking in cells and tissues without
neoplastic features or with a low likelihood of progression to
neoplastic features, such as hyperplastic epithelium.35
Consistent with this view, we found that Kras/KRAS-
mutant epithelium in hyperplastic lesions in mice and
humans had mitotic spindle polarity akin to that in normal
colon epithelium. Interestingly, in contrast to some previous
studies,36e38 we have not seen the defect in mitotic spindle
axis orientation in nondysplastic Apc heterozygous mutant
epithelium in our CDX2P-NLSCre Apcﬂox/þ mouse model.
This difference may be because heterozygous inactivation of
Apc by the CDX2P-NLSCre transgene only occurs in intes-
tine and colon epithelium at later stages of development or in
adult tissues, whereas Apc is constitutionally defective in
both colon epithelium and stromal cells in the Apcmin mouse
used in previous studies. In addition, the difference in results
may reﬂect our focus on the proximal colon epithelium
compared with the small intestine or distal colon in the work
on Apcmin mouse tissues.
In closing, we have described the generation and charac-
terization of CDX2P-CreERT2 transgenic mice, a new trans-
genic model that should prove to be very valuable for studies
of the physiologic functions of selected genes in colon
epithelium in vivo.Wehave found that biallelic inactivation of
Apc leads to many acute changes in proliferation, apoptosis,
and morphology, along with mitotic spindle axis misorien-
tation, b-catenin nuclear localization, and induction of stem
cell marker genes and the Sox9 transcription factor. The
robust induction of Sox9 in Apc-defective cells may be
contributing to the generation of ectopic Paneth-like cells in
adenomatous colon epithelium in humans and mice, and the
Paneth-like cells may play potentially important roles in
neoplastic crypt maintenance and progression. Future studies
with the CDX2P-CreERT2 transgenic mice are likely to
address various uncertainties about function of selected genes
in colon epithelium, such as the individual and collective
effects of oncogene and tumor suppressor gene defects in
CRC development. In addition, the CDX2P-CreERT2 trans-
genic mouse model may provide an important research tool
for assessing the potentially complex factors and interactions
contributing to colorectal tumor development, including how
dietary factors and the intestinal microenvironment and
immune system may intersect with genetic and epigenetic
factors in tumor initiation and progression.502Acknowledgments
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